Found 13 matching trials
FIND CAN Trial: "CF-172" NA The purpose of this feasibility study is to further explore characteristics...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC) PHASE2 The purpose of this study is to see whether receiving local ablative therap...
Show More Location
Hartford Healthcare ALLIANCE (Data collection only)
Learn More & Join Trial
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer PHASE2 The majority of patients with upper gastrointestinal cancer, such as gastri...
Show More Location
University Hospitals Leuven
Learn More & Join Trial
OMEGA, Local Ablative Therapy in Oligometastatic NSCLC PHASE3 Oligometastatic lung cancer (OM-NSCLC) seems to be associated with a better...
Show More Location
Azienda Ospedaliera Universitaria Integrata
Learn More & Join Trial
Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease NA This prospective national multicenter observational and interventional stud...
Show More Location
Copenhagen University Hospital Rigshospitalet
Learn More & Join Trial
Epicardial Ablation in Brugada Syndrome NA This prospective study evaluates the methodology and results of epicardial ...
Show More Location
IRCCS Policlinico S. Donato
Learn More & Join Trial
Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer PHASE2 This is an open-label, multicentre, randomized phase II clinical trial. Pat...
Show More Location
Department of Clinical Oncology, Prince of Wales Hospital
Learn More & Join Trial
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib PHASE2 Background:
Some non-small-cell lung cancers (NSCLC) have a mutation in a ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib PHASE2 The goal of this clinical trial is to learn if the treatment by systemic Br...
Show More Learn More & Join Trial
Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients NA Unfortunately, most patients are already at a very advanced stage when they...
Show More Location
Kantonspital Aarau
Learn More & Join Trial